Last edition
News about
Corvia Medical Responds to Trial Data, Emphasizes Patient Selection in Heart Failure Therapy
This therapy is currently under investigation in the global RESPONDER-HF trial of the Corvia® Atrial Shunt.
Lamassu Biotech Receives FDA Approval for Phase 1/2a Clinical Trials of Novel Cancer Therapy
This approval paves the way for the initiation of Phase 1/2a clinical trials for SA53-OS, a therapy designed to combat locally advanced metastatic p53 wild-type tumors.
Syntegon to Exhibit Highest Flexibility for Oral Solid Dosage Processing at Achema
An exemplary OSD production line and further exhibits give trade show visitors the opportunity to see this wide range of possibilities.
Orna Therapeutics Appoints Frank Neumann as CMO
Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNA®) announced that Frank Neumann, M.D., Ph.D., will join the Company as Chief Medical Officer.
TPM-1116 represents a new chemical series of OX2R agonists with the potential for a best-in-class clinical profile.
Sen-Jam Pharmaceutical and KVK-Tech to Provide CMC for Anti-Inflammatory Injectable
Sen-Jam Pharmaceutical has entered a third strategic collaboration with KVK-Tech.
Vertex Signs Agreement to Acquire Alpine Immune Sciences
Vertex Pharmaceuticals has signed a definitive agreement with Alpine Immune Sciences, a biotechnology company focused on discovering and developing innovative, protein-based immunotherapies.
Healx Secures Investment Agreement with Children's Tumor Foundation
The agreement entails payments from CTF to support the advancement of Healx's AI-powered neurofibromatosis program, particularly focusing on its lead candidate, HLX-1502, slated to enter a Phase 2 clinical trial in the near future.
Nuevocor Appoints Dr. John Lee as Chief Medical Officer
In response to his appointment, Dr. Lee expressed enthusiasm about joining Nuevocor and leading the clinical development efforts for the LMNA DCM program.
Dr. Reddys Unveils Drug-Free Migraine Management Device in Europe
Dr. Reddy’s Laboratories Ltd. has introduced the non-invasive migraine management wearable device, Nerivio in Germany through its step-down subsidiary Betapharm.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy